Correlation Between Pfizer and Spectra7 Microsystems

Can any of the company-specific risk be diversified away by investing in both Pfizer and Spectra7 Microsystems at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Spectra7 Microsystems into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Spectra7 Microsystems, you can compare the effects of market volatilities on Pfizer and Spectra7 Microsystems and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Spectra7 Microsystems. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Spectra7 Microsystems.

Diversification Opportunities for Pfizer and Spectra7 Microsystems

-0.29

Correlation Coefficient

Pfizer  Spectra7 Microsystems

Very good diversification

The 3 months correlation between Pfizer and Spectra7 is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Spectra7 Microsystems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spectra7 Microsystems and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Spectra7 Microsystems. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spectra7 Microsystems has no effect on the direction of Pfizer i.e., Pfizer and Spectra7 Microsystems go up and down completely randomly.

Pair Corralation between Pfizer and Spectra7 Microsystems

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Spectra7 Microsystems. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 6.2 times less risky than Spectra7 Microsystems. The stock trades about -0.06 of its potential returns per unit of risk. The Spectra7 Microsystems is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  44.00  in Spectra7 Microsystems on October 7, 2024 and sell it today you would lose (35.83) from holding Spectra7 Microsystems or give up 81.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Pfizer Inc  vs.  Spectra7 Microsystems

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Spectra7 Microsystems

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Spectra7 Microsystems are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Spectra7 Microsystems reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Spectra7 Microsystems

The main advantage of trading using opposite Pfizer and Spectra7 Microsystems positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Spectra7 Microsystems can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectra7 Microsystems will offset losses from the drop in Spectra7 Microsystems' long position.

The idea behind Pfizer Inc and Spectra7 Microsystems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.